I have more than ten years of experience. Since my graduation, I have been working at the Department of Cardiology at the Hungarian Army Medical Center which works on a three-stage basis. Here I acquired experience in acute and chronic cardiological disorders diagnostics and complex treatment. My cardiological interest is wide, but in my scientific activity I mainly carry out research in the areas of heart failure and medicinal and instrumental treatment.
My main profile at Buda Health Center is cardiological non-invasive diagnostical treatments (identification of heart diseases,– diagnostics and echocardiographical – heart ultrasound – examinations). I treat patients with heart or vascular system problems.
- Complex treatment of acute and chronic heart failure
- Medicinal and instrumental treatment for coronary artery disease and myocardial infarction
- 2009 – : Hungarian Army Medical Center
- Internal medicine physician
- 2019 – : Buda Health Center
Education and qualifications
- 2009: Faculty of Medicine – Semmelweis University
- 2015: qualifying exam in internal medicine
- 2017: qualifying exam in cardiology
- 2017: European Society of Cardiology, ESC, ESC Heart Failure International license.
- 2017: Hungarian echocardiographic license, Semmelweis University
- 2018 – 2019: SACVS (Servier Advanced Cardiovascular School) Heart Failure specialist postgraduate course
- 2020: PCHF (Postgraduate Course in Heart Failure), London, Heart Failure specialist postgraduate course
Professional and society membership
- Hungarian Society of Cardiology
- European Society of Cardiology
- ESC Heart Failure Association
- European Association of Percutaneous Cardiovascular Interventions
- European Association of Cardiovascular Imaging
- B. Muk1, M. Dekany1, N Nyolczas1, B. Szabo1, B. Ancsin1, B. Polgar1, T. Borsanyi1, RG. Kiss1 (1) Military Hospital, Budapest, Hungary: “Long term mineralocorticoid-receptor antagonist treatment in patients managed at a heart failure outpatient clinic”.. European Journal of Heart Failure Supplements (2012) 11 (S1) , S39
- B. Muk1, M. Dekany1, B. Szabo1, B. Ancsin1, T. Borsanyi1, M. Vamos1, D. Vagany1, GZ. Duray1, RG. Kiss1, N. Nyolczas1- 1 Military Hospital, Budapest, Hungary: “The change of the proportion of patients with indication for ivabradin treatment in the effect of optimal therapy in systolic heart failure” European Journal of Heart Failure (2013) 15 (S1), S299
- B. Muk1, B. Szabo1, M. Dekany1, ZS. Majoros1, P. Bogyi1, T. Borsanyi1, D. Vagany1, M. Szabo1, RG. Kiss1, N. Nyolczas1 1Medical Centre, Hungarian Defence Forces, Cardiology, Budapest, Hungary: “Changes in systolic blood pressure, pulse pressure and proportional pulse pressure in the effect of optimal medical therapy in a real-life patient population with severe systolic heart failure” European Journal of Heart Failure 2014 European Society of Cardiology, 16 (Suppl. 2), 5– 365; P824
- B. Muk1, M. Dekany1, B. Szabo1, ZS. Majoros1, P. Bogyi1, D. Vagany1, M. Szabo1, B. Polgar1, RG. Kiss1, N. Nyolczas1 1Medical Centre, Hungarian Defence Forces, Cardiology, Budapest, Hungary: “The changes and prognostic value of pulse pressure and proportional pulse pressure in different systolic blood pressure range subgroups of severe systolic heart failure patients” European Heart Journal (2014) 35 (Abstract Supplement ): P846-847
- B. Muk1; B. Szabo2; M. Dekany1; ZS. Majoros1; T. Borsanyi1; D. Vagany1; B. Polgar1; M. Szabo1; RG. Kiss1; N. Nyolczas1 1Medical Centre, Hungarian Defence Forces, Cardiology, Budapest, Hungary: 2 Orebro University, Faculty of Health, Cardiology , Orebro, “The proportion of patients suitable for ARNI treatment before and after optimal therapy in HFrEF” ; Sweden Eur Heart J (2015) 36 (suppl 1): 509-84
- B. Muk1, B. Szabo2, M. Dekany1, P. Bogyi1, D. Vagany1, ZS. Majoros1, T. Borsanyi1, K. Bozo1, R.G. Kiss1, N. Nyolczas1. 1Medical Centre, Hungarian Defence Forces, Cardiology, Budapest, Hungary 2 Orebro University, Faculty of Health, Cardiology, Orebro; “The effect of treatment optimization on the suitability of ARNI among patients followed at a heart failure outpatient clinic”, Sweden Eur Heart J (2015) 36 (suppl 1): P556
- B. Muk1, ZS. Majoros1, D. Vagany1, L. Gopcsa2, P. Bogyi1, B. Sax3, T. Masszi2, B. Merkely3, R.G. Kiss1, N. Nyolczas1 1Medical Centre, Hungarian Defence Forces, Cardiology, Budapest, Hungary; 2St Istvan and St Laszlo Hospital, First Department of Haematology and Stem Cell Transplantation, Budapest, Hungary; 3Semmelweis University, Heart and Vascular Center, Budapest, Hungary: “All for one and one for all, when one transplant is not enough” Eur Heart J (2016) 37(Suppl 1): P1425
- M. Vamos, N. Nyolczas, Z. Bari, P. Bogyi, B. Muk, B. Szabo, B. Ancsin, RG. Kiss, GZ. Duray: “Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients”. Cardiol J. 2017 Jun 27. doi: 10.5603/CJ.a2017.0077.
- N.Nyolczas,M.Dékány,B.Muk,B.Szabó: “Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.”AdvExpMedBiol.2017 Oct 31. doi: 10.1007/5584_2017_112.
Should You like to make an appointment with our collegue for private consultation, please dial the number +36-1-489-5200, where our dispatchers will answer your call between 8am and 8pm every weekday!